Impax Asset Management Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $34.1M | Buy |
134,357
+17,041
| +15% | +$3.97M | 0.22% | 81 |
|
|
2026
Q1 | $28.7M | Buy |
117,316
+8,919
| +8% | +$2.08M | 0.2% | 87 |
|
|
2025
Q4 | $22.4M | Sell |
108,397
-13,060
| -11% | -$2.58M | 0.14% | 101 |
|
|
2025
Q3 | $22.5M | Buy |
121,457
+15,594
| +15% | +$2.67M | 0.13% | 95 |
|
|
2025
Q2 | $16.2M | Buy |
105,863
+40,845
| +63% | +$6.28M | 0.09% | 114 |
|
|
2025
Q1 | $10.8M | Sell |
65,018
-4,333
| -6% | -$678K | 0.06% | 138 |
|
|
2024
Q4 | $10M | Sell |
69,351
-2,604
| -4% | -$404K | 0.05% | 162 |
|
|
2024
Q3 | $11.7M | Sell |
71,955
-44,851
| -38% | -$7.15M | 0.05% | 151 |
|
|
2024
Q2 | $17.1M | Sell |
116,806
-1,790
| -2% | -$266K | 0.07% | 134 |
|
|
2024
Q1 | $18.8M | Buy |
118,596
+31,692
| +36% | +$5.04M | 0.07% | 133 |
|
|
2023
Q4 | $13.6M | Buy |
86,904
+6,209
| +8% | +$952K | 0.05% | 148 |
|
|
2023
Q3 | $12.6M | Sell |
80,695
-16,730
| -17% | -$2.76M | 0.06% | 139 |
|
|
2023
Q2 | $16.1M | Buy |
97,425
+924
| +1% | +$149K | 0.06% | 134 |
|
|
2023
Q1 | $15M | Buy |
96,501
+148
| +0.2% | +$23.9K | 0.06% | 132 |
|
|
2022
Q4 | $17M | Sell |
96,353
-16,664
| -15% | -$2.88M | 0.08% | 124 |
|
|
2022
Q3 | $18.5M | Sell |
113,017
-3,149
| -3% | -$533K | 0.09% | 120 |
|
|
2022
Q2 | $20.6M | Sell |
116,166
-5,128
| -4% | -$914K | 0.1% | 114 |
|
|
2022
Q1 | $21.5M | Buy |
121,294
+1,482
| +1% | +$252K | 0.09% | 123 |
|
|
2021
Q4 | $20.5M | Sell |
119,812
-557
| -0.5% | -$91.2K | 0.07% | 128 |
|
|
2021
Q3 | $19.4M | Buy |
120,369
+318
| +0.3% | +$54.3K | 0.08% | 123 |
|
|
2021
Q2 | $19.8M | Sell |
120,051
-34
| -0% | -$5.63K | 0.09% | 117 |
|
|
2021
Q1 | $19.7M | Buy |
120,085
+40,225
| +50% | +$6.51M | 0.1% | 107 |
|
|
2020
Q4 | $12.6M | Buy |
79,860
+7,139
| +10% | +$1.05M | 0.08% | 112 |
|
|
2020
Q3 | $10.8M | Buy |
72,721
+2,366
| +3% | +$350K | 0.09% | 112 |
|
|
2020
Q2 | $9.89M | Buy |
70,355
+1,679
| +2% | +$245K | 0.1% | 117 |
|
|
2020
Q1 | $9.01M | Buy |
68,676
+11,209
| +20% | +$1.59M | 0.12% | 107 |
|
|
2019
Q4 | $8.38M | Buy |
57,467
+4,970
| +9% | +$674K | 0.09% | 131 |
|
|
2019
Q3 | $6.79M | Buy |
52,497
+5,089
| +11% | +$670K | 0.09% | 146 |
|
|
2019
Q2 | $6.6M | Buy |
47,408
+4,654
| +11% | +$644K | 0.09% | 140 |
|
|
2019
Q1 | $5.98M | Buy |
42,754
+6,245
| +17% | +$837K | 0.08% | 144 |
|
|
2018
Q4 | $4.71M | Buy |
36,509
+1,139
| +3% | +$159K | 0.08% | 158 |
|
|
2018
Q3 | $4.89M | Buy |
+35,370
| New | +$4.7M | 0.07% | 165 |
|
Other funds holding JNJ
Impax Asset Management Group's JNJ Position: Q2 2026 in Review
Impax Asset Management Group increased its Johnson & Johnson (JNJ) stake by 15% in Q2 2026, buying an estimated $3.97M and bringing the position to 134,357 shares worth $34.1M. The position accounts for 0.22% of the portfolio, ranked #81.
Impax Asset Management Group first reported a position in JNJ in Q3 2018 and has held it in 32 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Impax Asset Management Group held 134,357 shares of Johnson & Johnson worth $34.1M as of Q2 2026.
- Impax Asset Management Group bought 17,041 Johnson & Johnson shares in Q2 2026, an estimated $3.97M.
- Johnson & Johnson made up 0.22% of Impax Asset Management Group's portfolio in Q2 2026, its #81 holding.
- Impax Asset Management Group first reported a position in Johnson & Johnson in Q3 2018 and has held it in 32 quarters since.
- 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.